Sequential endocrine therapy and chemotherapy in metastatic breast cancer: Effects on survival

[1]  Moustafa,et al.  Combination chemotherapy in advanced breast cancer , 1984 .

[2]  R. S. Rhodes,et al.  Adjuvant chemotherapy, antiestrogen therapy and immunotherapy for stage II breast cancer: 45‐month follow‐up of a prospective, randomized clinical trial , 1980, Cancer.

[3]  A. Manni,et al.  Effect of hypophysectomy and hormone replacement of hormone receptor levels and the growth of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat. , 1980, Endocrinology.

[4]  A. Manni,et al.  Antiestrogen-induced remissions in premenopausal women with stage IV breast cancer: effects on ovarian function. , 1980, Cancer treatment reports.

[5]  A. Manni,et al.  Sequential use of endocrine therapy and chemotherapy for metastatic breast cancer: effects on survival. , 1980, Cancer treatment reports.

[6]  K. Pritchard,et al.  Tamoxifen Response - a Useful Guide to Subsequent Treatment in Premenopausal Patients with Metastatic Breast-Cancer , 1980 .

[7]  K. Pritchard,et al.  Tamoxifen therapy in premenopausal patients with metastatic breast cancer. , 1980, Cancer treatment reports.

[8]  W. McGuire,et al.  Adjuvant chemotherapy, anti-estrogen therapy and immunotherapy for stage II breast cancer. , 1980, European journal of cancer.

[9]  A. Manni,et al.  Antihormone treatment of stage IV breast cancer , 1979, Cancer.

[10]  J. Bertino,et al.  Combination chemotherapy for advanced breast cancer. Two regimens containing adriamycin , 1978, Cancer.

[11]  A. Manni,et al.  Antiestrogen-induced remissions in stage IV breast cancer. , 1976, Cancer treatment reports.

[12]  V. Devita,et al.  Combination chemotherapy for advanced breast cancer: response and effect on survival. , 1976, Annals of internal medicine.